Tandem Diabetes Care Inc (TNDM)
Tandem Diabetes Care, Inc. is a healthcare technology company focused on products and software for people living with diabetes in the United States and international markets. The company’s portfolio includes the t:slim X2 insulin delivery system and the Tandem Mobi insulin pump, which is designed for automated insulin delivery. It also sells disposable supplies such as insulin cartridges and infusion sets that support pump use. In addition, Tandem provides software and digital tools, including Tandem Device Updater for remote pump software updates, Tandem Source for diabetes data management, and Sugarmate for viewing therapy data through a mobile app. The company also collaborates with the University of Virginia Center for Diabetes Technology on research related to fully automated closed-loop insulin delivery systems. Tandem Diabetes Care was incorporated in 2006, adopted its current name in 2008, and is based in San Diego, California.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NASDAQ-TNDM
|
$17.30
|
-0.1% Downside
|
Fair
|
$29.08
|
67.9% Upside
|
Bargain
|
Good
|
—
|
—
|
—
|
0.0%
|
August 6, 2026
|
-12.6x
|
9.0x
|
1.2x
|
1.24 B
|
1.298 B
|
37.2%
|
91.8%
|
0.6
|
—
|
3.8%
|
